$25.7064
+0.4
(+1.57%)▲
Insights on Healthstream Inc
Revenue is up for the last 9 quarters, 64.09M → 70.33M (in $), with an average increase of 1.2% per quarter
Netprofit is down for the last 2 quarters, 4.13M → 3.86M (in $), with an average decrease of 6.4% per quarter
In the last 1 year, 10x Genomics Inc has given 17.4% return, outperforming this stock by 18.4%
2.7%
Downside
Day's Volatility :2.89%
Upside
0.19%
20.58%
Downside
52 Weeks Volatility :25.93%
Upside
6.75%
Period | Healthstream Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 20.07% | -1.3% | 0.0% |
6 Months | 7.66% | 1.2% | 0.0% |
1 Year | 0.84% | -5.7% | -6.5% |
3 Years | 26.8% | 17.1% | -6.5% |
Market Capitalization | 781.4M |
Book Value | $11.19 |
Dividend Share | 0.075 |
Dividend Yield | 0.39% |
Earnings Per Share (EPS) | 0.43 |
PE Ratio | 60.0 |
PEG Ratio | 6.85 |
Wall Street Target Price | 24.0 |
Profit Margin | 4.72% |
Operating Margin TTM | 6.91% |
Return On Assets TTM | 1.92% |
Return On Equity TTM | 3.89% |
Revenue TTM | 277.0M |
Revenue Per Share TTM | 9.04 |
Quarterly Revenue Growth YOY | 4.5% |
Gross Profit TTM | 175.7M |
EBITDA | 36.3M |
Diluted Eps TTM | 0.43 |
Quarterly Earnings Growth YOY | 0.05 |
EPS Estimate Current Year | 0.44 |
EPS Estimate Next Year | 0.47 |
EPS Estimate Current Quarter | 0.09 |
EPS Estimate Next Quarter | 0.09 |
What analysts predicted
Downside of 6.64%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 247.7M | ↑ 9.6% |
Net Income | 10.0M | ↑ 166.42% |
Net Profit Margin | 4.04% | ↑ 2.38% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 231.6M | ↓ 6.48% |
Net Income | 32.2M | ↑ 222.04% |
Net Profit Margin | 13.91% | ↑ 9.87% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 254.1M | ↑ 9.71% |
Net Income | 15.8M | ↓ 51.05% |
Net Profit Margin | 6.21% | ↓ 7.7% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 244.8M | ↓ 3.65% |
Net Income | 14.1M | ↓ 10.65% |
Net Profit Margin | 5.76% | ↓ 0.45% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 256.7M | ↑ 4.85% |
Net Income | 5.8M | ↓ 58.52% |
Net Profit Margin | 2.28% | ↓ 3.48% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 266.8M | ↑ 3.94% |
Net Income | 12.1M | ↑ 106.86% |
Net Profit Margin | 4.53% | ↑ 2.25% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 65.6M | ↑ 0.41% |
Net Income | 3.1M | ↑ 6.57% |
Net Profit Margin | 4.7% | ↑ 0.27% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 67.3M | ↑ 2.51% |
Net Income | 3.7M | ↑ 18.91% |
Net Profit Margin | 5.45% | ↑ 0.75% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 68.5M | ↑ 1.86% |
Net Income | 2.5M | ↓ 33.14% |
Net Profit Margin | 3.58% | ↓ 1.87% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 68.9M | ↑ 0.6% |
Net Income | 2.6M | ↑ 7.02% |
Net Profit Margin | 3.8% | ↑ 0.22% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 69.2M | ↑ 0.37% |
Net Income | 4.1M | ↑ 57.57% |
Net Profit Margin | 5.97% | ↑ 2.17% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.3M | ↑ 1.65% |
Net Income | 3.9M | ↓ 6.44% |
Net Profit Margin | 5.5% | ↓ 0.47% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 411.1M | ↑ 3.81% |
Total Liabilities | 110.9M | ↑ 0.92% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 440.2M | ↑ 7.08% |
Total Liabilities | 121.2M | ↑ 9.3% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 489.5M | ↑ 11.22% |
Total Liabilities | 151.4M | ↑ 24.88% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 500.3M | ↑ 2.2% |
Total Liabilities | 166.3M | ↑ 9.83% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 486.8M | ↓ 2.71% |
Total Liabilities | 147.7M | ↓ 11.14% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 497.7M | ↑ 2.26% |
Total Liabilities | 163.7M | ↑ 10.79% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 477.7M | ↓ 1.29% |
Total Liabilities | 151.0M | ↓ 6.43% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 481.2M | ↑ 0.73% |
Total Liabilities | 150.9M | ↓ 0.04% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 497.7M | ↑ 3.44% |
Total Liabilities | 163.7M | ↑ 8.46% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 503.2M | ↑ 1.09% |
Total Liabilities | 167.1M | ↑ 2.1% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 493.5M | ↓ 1.92% |
Total Liabilities | 152.9M | ↓ 8.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 498.1M | ↑ 0.93% |
Total Liabilities | 155.8M | ↑ 1.93% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 46.7M | ↑ 92.75% |
Investing Cash Flow | -11.6M | ↓ 79.56% |
Financing Cash Flow | 1000.0 | ↓ 97.83% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 43.2M | ↓ 7.42% |
Investing Cash Flow | 36.6M | ↓ 415.73% |
Financing Cash Flow | -30.3M | ↓ 3025200.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 65.7M | ↑ 51.82% |
Investing Cash Flow | -67.5M | ↓ 284.7% |
Financing Cash Flow | -916.0K | ↓ 96.97% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 35.9M | ↓ 45.36% |
Investing Cash Flow | -110.4M | ↑ 63.51% |
Financing Cash Flow | -20.5M | ↑ 2137.34% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 42.4M | ↑ 18.15% |
Investing Cash Flow | -25.7M | ↓ 76.7% |
Financing Cash Flow | -6.2M | ↓ 69.7% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.3M | ↓ 64.53% |
Investing Cash Flow | -10.0M | ↑ 152.85% |
Financing Cash Flow | -3.4M | ↓ 83.13% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 15.1M | ↑ 106.1% |
Investing Cash Flow | -4.0M | ↓ 59.6% |
Financing Cash Flow | -20.0K | ↓ 99.41% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 20.5M | ↑ 153.34% |
Investing Cash Flow | -16.9M | - |
Financing Cash Flow | -791.0K | ↑ 1582.98% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.9M | ↓ 75.91% |
Investing Cash Flow | -26.4M | ↑ 55.94% |
Financing Cash Flow | -1.5M | ↑ 94.69% |
Sell
Neutral
Buy
Healthstream Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Healthstream Inc | -1.25% | 7.66% | 0.84% | 26.8% | 3.77% |
![]() 10x Genomics Inc | 18.37% | -16.79% | 25.1% | -69.3% | -13.27% |
![]() Veeva Systems Inc. | -8.82% | -7.55% | 6.94% | -34.18% | 92.3% |
![]() Ge Healthcare Technologies Inc. | -2.36% | -13.77% | 14.75% | 14.75% | 14.75% |
![]() Healthequity Inc | 3.27% | 17.93% | 2.45% | -1.71% | -17.0% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Healthstream Inc | 60.0 | 60.0 | 6.85 | 0.44 | 0.04 | 0.02 | 0.0 | 11.19 |
![]() 10x Genomics Inc | NA | NA | NA | -2.12 | -0.29 | -0.12 | 0.0 | 6.31 |
![]() Veeva Systems Inc. | 53.18 | 53.18 | 1.27 | 4.18 | 0.15 | 0.05 | 0.0 | 25.85 |
![]() Ge Healthcare Technologies Inc. | 21.87 | 21.87 | NA | 3.82 | 0.15 | 0.06 | 0.0 | 15.67 |
![]() Healthequity Inc | 456.6 | 456.6 | 1.92 | 1.33 | 0.01 | 0.02 | 0.0 | 22.77 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Healthstream Inc | Buy | $781.4M | 3.77% | 60.0 | 4.72% |
![]() 10x Genomics Inc | Buy | $5.1B | -13.27% | NA | -37.79% |
![]() Veeva Systems Inc. | Buy | $28.4B | 92.3% | 53.18 | 24.2% |
![]() Ge Healthcare Technologies Inc. | Buy | $33.6B | 14.75% | 21.87 | 8.91% |
![]() Healthequity Inc | Buy | $5.9B | -17.0% | 456.6 | 1.37% |
BlackRock Inc
Vanguard Group Inc
Dimensional Fund Advisors, Inc.
State Street Corporation
Punch & Associates Inv Mgmt Inc
Acadian Asset Management LLC
thousands of healthcare providers, including half of u.s. hospitals, have chosen healthstream (nasdaq: hstm) as their partner for improving clinical and business outcomes. in this new era of healthcare reform, meaningful use, and value-based purchasing, hundreds of leading organizations each year are switching to healthstream to elevate the role of learning and development in addressing these challenges. our vision healthstream’s vision is to improve the quality of healthcare by assessing and developing the people who deliver care.
Organization | Healthstream Inc |
Employees | 1135 |
CEO | Mr. Robert A. Frist Jr. |
Industry | Technology Services |
Asymmetric Smart Alpha S&p 500 Etf
$25.71
+1.57%
Advisorshares Alpha Dna Equity Sentiment Etf
$25.71
+1.57%
Liberty Tripadvisor Hdg-b
$25.71
+1.57%
Tempo Automation Holdings Inc
$25.71
+1.57%
Falcon's Beyond Global Inc
$25.71
+1.57%
Jaguar Global Growth Corporation I
$25.71
+1.57%
Missfresh Ltd
$25.71
+1.57%
Shuaa Partners Acquisition Corp I
$25.71
+1.57%
Rose Hill Acquisition Corp
$25.71
+1.57%